Effect of Topiramate on Weight Status in Young Children With Severe Obesity
Topiramate monotherapy resulted in significant BMI reductions in young children with severe obesity, including those with hypothalamic obesity. Further prospective randomized controlled trials are warranted to assess its long-term efficacy for obesity management in young children.
Authors
- Siobhán T. Pittock (ORCID: https://orcid.org/0000-0002-2616-7349)
- Doha Hassan (ORCID: https://orcid.org/0000-0003-1806-4873)
- Mostafa Salama (ORCID: https://orcid.org/0009-0001-7451-1503)
- Aida Nadim Lteif
- Seema Kumar (ORCID: https://orcid.org/0000-0001-8004-4924)
Institutions
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1210/jendso/bvaf179
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00